The use of bacteria producing the aminoglycoside inactivating enzyme ANT-(2'') in an in-vitro model
- 1 January 1985
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 15 (suppl A) , 251-256
- https://doi.org/10.1093/jac/15.suppl_a.251
Abstract
A series of transconjugants of Eschenchia coli W3110 containing different plasmids coding for the aminoglycoside inactivating enzyme ANT-(2″) were tested in an in-vitro model simulating the concentration time curves of aminoglycosides after intramuscular administration of 80 or 120 mg There was good correlation of the MIC, which ranged from 2 to 32 mg/1, with the killing ability of the drugs. A second dose had no or only little effect on ANT-(2″) producing strains. All strains, although of ‘intermediate’ sensitivity were found to be resistant in the in-vitro model. Only netilmicin could eliminate some of the strains but its activity on ANT-(2″)-positive strains was not as good as on ANT-(2″)-negative ones.Keywords
This publication has 0 references indexed in Scilit: